ASML Holding N.V. (ASMLF) vs Eli Lilly and Company (LLY)

See how ASML Holding N.V. and Eli Lilly and Company differ across market data and performance, so you can decide which asset best fits your strategy.

$1,278.23
OTC Markets OTCPK
View Full Page
$1,354.82
NYSE
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.
View Full Page

Key Metrics Comparison

ASML Holding N.V.ASMLF
Market Cap
$492.652B
Price
$1,278.23
24h Change
-7.80%
24h Volume
$8
Employees
44,681
Shares Outstanding
N/A
Eli Lilly and CompanyLLY
Market Cap
$1.207T
Price
$1,354.82
24h Change
+0.27%
24h Volume
$1.28M
Employees
50,000
Shares Outstanding
944,818,881

Category Performance

Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.

Market Share

Share of combined market cap

Market Share
ASMLF
29.0%
LLY
71.0%

Volume Share

Share of combined 24h volume

Volume Share
ASMLF
1.0%
LLY
100.0%

24h Performance

Price change over last 24 hours

24h Performance
ASMLF
-7.80%
LLY
0.27%
Price Comparison
ASML Holding N.V.
Eli Lilly and Company